The protein kinase DYRK1B is a p53 target gene and functions as a negative feedback regulator of the transcription factor RFX7. [PDF]
Wilms G +8 more
europepmc +1 more source
Emerging Strategies to Inhibit the G1/S Transition for Cancer Therapy. [PDF]
Rubin SM, Sage J, Skotheim JM.
europepmc +1 more source
ZRMQ-22, a novel DYRK1A inhibitor, attenuates neuroinflammation and cognitive impairments in LPS-induced mice: a potential strategy for Alzheimer's disease. [PDF]
Ren M +14 more
europepmc +1 more source
Pharmacokinetics, distribution, metabolism, excretion and safety characterization of ZJCK-6-72: novel DYRK1A inhibitor with optimized brain exposure for Alzheimer's disease therapy. [PDF]
Li Z +15 more
europepmc +1 more source
Targeting dual specificity tyrosine-phosphorylation-regulated kinase 1A mitigates tauopathy and enhances recovery after repetitive head injury. [PDF]
Melchior B +10 more
europepmc +1 more source
Critical role of the CMGC insert sequence for tyrosine autophosphorylation in the protein kinase DYRK1B. [PDF]
Detro-Dassen S +4 more
europepmc +1 more source
Single-cell profiling reveals FAM117A as a key regulator linking macrophage-epithelial crosstalk with the progression of lung adenocarcinoma. [PDF]
Wu C +8 more
europepmc +1 more source
Promoting Research Excellence in Down Syndrome: Proceedings of the 5th International Conference of the Trisomy 21 Research Society. [PDF]
Di Domenico F +43 more
europepmc +1 more source
CMGC Kinases in Viral Infection and Human Disease. [PDF]
Amusan OT, Guo H.
europepmc +1 more source
Geometry-based BERT: An experimentally validated deep learning model for molecular property prediction in drug discovery. [PDF]
Zhang X +7 more
europepmc +1 more source

